Neda K./LinkedIn
Apr 23, 2026, 16:55
Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
Neda K., Clinical Pharmacist, shared a post on LinkedIn:
”Perioperative Management of Antithrombotic: When to Hold Therapy
Perioperative management of antithrombotic therapy is all about balancing bleeding and thrombotic risks. The holding times for each agent are outlined in the image below.
Bridging Therapy: Who Really Needs It?
Indications for bridging when interrupting vitamin K antagonists:
Consider only in high thrombotic risk, such as:
- Mechanical heart valves
- Recent venous thromboembolism (VTE) (less than 3 months)
- Very high-risk atrial fibrillation
How to bridge?
- Discontinue warfarin 5 days before surgery.
- Start LMWH or UFH at therapeutic doses 3 days before surgery.
- Discontinue LMWH 24 hours or UFH 4 to 6 hours before surgery.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care